A controlled trial of rifampicin, minocycline, and rifampicin plus minocycline for eradication of methicillin-resistant Staphylococcus aureus in long-term care patients.
R R
RR
Muder
M
M
Boldin
C
C
Brennen
M
M
Hsieh
R M
RM
Vickers
K
K
Mitchum
Y C
YC
Yee
D002404:Catheterization / Q000009:adverse effects; D004359:Drug Therapy, Combination / Q000627:therapeutic use*; D006801:Humans; D008134:Long-Term Care; D016106:Methicillin Resistance; D008826:Microbial Sensitivity Tests; D008911:Minocycline / Q000627:therapeutic use*; D009296:Nasal Cavity / Q000382:microbiology; D010865:Pilot Projects; D012293:Rifampin / Q000627:therapeutic use*; D012307:Risk Factors; D013203:Staphylococcal Infections / Q000382:microbiology / Q000517:prevention & control* / Q000652:urine; D013211:Staphylococcus aureus / Q000187:drug effects*
D008911:Minocycline; D012293:Rifampin